1887

Abstract

A correlation between over baseline (DOB) values of the [C]urea breath test (UBT) and clarithromycin resistance has been reported, suggesting a possible predictive role of UBT in therapeutic outcome. However, available data are limited and conflicting. This study aimed to clarify this issue, assessing the possible relationship between resistance towards different antibiotics (clarithromycin, metronidazole and levofloxacin) and UBT values. The data showed similar DOB values between susceptible and resistant strains for clarithromycin (46.9±32.3 vs 45.7±30.6; =0.8), metronidazole (46.4±29.6 vs 47.4±37.9; =0.8), and levofloxacin (45.0±30.2 vs 54.2±38.4; =0.08). Likewise, comparable DOB values were observed between susceptible and multidrug-resistant strains (45.4±29.6 vs 54.8±44.8; =0.1). In conclusion, our data failed to find a significant correlation between UBT values and antibiotic resistance.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.018077-0
2010-05-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/5/588.html?itemId=/content/journal/jmm/10.1099/jmm.0.018077-0&mimeType=html&fmt=ahah

References

  1. Buzás, G. M. & Széles, I. ( 2008; ). Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection. J Gastroenterol 43, 108–114.[CrossRef]
    [Google Scholar]
  2. Cremonini, F., Bartolozzi, F., Armuzzi, A., Zocco, M. A., Santarelli, L., Gabrielli, M., Candelli, M., Nista, E. C., Santoliquido, A. & Gasbarrini, A. ( 2005; ). Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? Hepatogastroenterology 52, 1119–1121.
    [Google Scholar]
  3. De Francesco, V., Margiotta, M., Zullo, A., Hassan, C., Troiani, L., Burattini, O., Stella, F., Di Leo, A., Russo, F. & other authors ( 2006a; ). Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 144, 94–100.[CrossRef]
    [Google Scholar]
  4. De Francesco, V., Margiotta, M., Zullo, A., Hassan, C., Valle, N. D., Burattini, O., Cea, U., Stoppino, G., Amoruso, A. & other authors ( 2006b; ). Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther 23, 429–435.[CrossRef]
    [Google Scholar]
  5. De Francesco, V., Margiotta, M., Zullo, A., Hassan, C., Valle, N. D., Burattini, O., D'Angelo, R., Stoppino, G., Cea, U. & other authors ( 2006c; ). Clarithromycin resistance and Helicobacter pylori genotypes in Italy. J Microbiol 44, 660–664.
    [Google Scholar]
  6. De Francesco, V., Margiotta, M., Zullo, A., Hassan, C., Valle, N. D., Burattini, O., Cea, U., Stoppino, G., Amoruso, A. & other authors ( 2007; ). Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimicrob Chemother 59, 783–785.[CrossRef]
    [Google Scholar]
  7. Gerard, C. J., Olsson, K., Ramanathan, R., Reading, C. & Hanania, E. G. ( 1998; ). Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res 58, 3957–3964.
    [Google Scholar]
  8. Kao, A. W., Cheng, H. C., Sheu, B. S., Lin, C. Y., Sheu, M. J., Yang, H. B. & Wu, J. J. ( 2005; ). Posttreatment 13C urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy. J Gen Intern Med 20, 139–142.[CrossRef]
    [Google Scholar]
  9. Kawai, T., Kawakami, K., Kataoka, M., Itoi, T., Takei, K., Moriyasu, F., Takagi, Y., Aoki, T., Serizawa, H. & other authors ( 2008; ). A study of the relationship between Helicobacter pylori microbial susceptibility, 13C-urea breath test values. Hepatogastroenterology 55, 786–790.
    [Google Scholar]
  10. Megraud, F. ( 2004; ). H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53, 1374–1384.[CrossRef]
    [Google Scholar]
  11. Owen, R. J. ( 2002; ). Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50, 285–288.[CrossRef]
    [Google Scholar]
  12. Perri, F., Clemente, R., Pastore, M., Quitadamo, M., Festa, V., Bisceglia, M., Li Bergli, M., Lauriola, G., Leandro, G. & other authors ( 1998; ). The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest 58, 19–27.[CrossRef]
    [Google Scholar]
  13. Sarker, S. A., Nahar, S., Rahman, M., Bardhan, P. K., Nair, G. B., Beglinger, C. & Gyr, N. ( 2004; ). High prevalence of cagA and vacA seropositivity in asymptomatic Bangladeshi children with Helicobacter pylori infection. Acta Paediatr 93, 1432–1436.[CrossRef]
    [Google Scholar]
  14. Vaira, D. & Vakil, N. ( 2001; ). Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 48, 287–289.[CrossRef]
    [Google Scholar]
  15. Zagari, R. M., Pozzato, P., Martuzzi, C., Fuccio, L., Martinelli, G., Roda, E. & Bazzoli, F. ( 2005; ). 13C-Urea breath test to assess Helicobacter pylori bacterial load. Helicobacter 10, 615–619.[CrossRef]
    [Google Scholar]
  16. Zullo, A., Hassan, C., Lorenzetti, R., Winn, S. & Morini, S. ( 2003; ). A clinical practice viewpoint: to culture or not to culture Helicobacter pylori? Dig Liver Dis 35, 357–361.[CrossRef]
    [Google Scholar]
  17. Zullo, A., Sanchez-Mete, L., Hassan, C., Diana, F., Festuccia, F., Attili, A. F. & Morini, S. ( 2004; ). Helicobacter pylori density and cagA status in cirrhotic patients: a case-control study. J Gastroenterol Hepatol 19, 1174–1178.[CrossRef]
    [Google Scholar]
  18. Zullo, A., Perna, F., Hassan, C., Ricci, C., Saracino, I., Morini, S. & Vaira, D. ( 2007; ). Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 25, 1429–1434.[CrossRef]
    [Google Scholar]
  19. Zullo, A., Perna, F., Ricci, C., Hassan, C., Tampieri, A., De Francesco, V., Morini, S. & Vaira, D. ( 2008; ). 13C-urea breath test values and Helicobacter pylori eradication. Dig Dis Sci 53, 370–374.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.018077-0
Loading
/content/journal/jmm/10.1099/jmm.0.018077-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error